Instituto De Oftalmología Fundación Conde De Valenciana
Clinical trials sponsored by Instituto De Oftalmología Fundación Conde De Valenciana, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo treatment may sharpen vision in keratoconus patients Results expected Sep 2026 (estimated)
- Immune cell study may unlock clues to better allergy eye treatments Results expected Sep 2026 (estimated)
- Hospital study tracks eye drop risks in 1,000 patients Results expected Sep 2026 (estimated)
- Mexican eye measurements could sharpen diagnosis of orbital diseases Results expected Dec 2026 (estimated)
- Tear and blood molecules may unlock secrets of eye allergies Results expected Jan 2027 (estimated)
-
Laser eye surgery showdown: which fix for nearsightedness is better?
Disease control OngoingThis study compares two common laser eye surgeries—KLEx and FS-LASIK—for treating nearsightedness and astigmatism. Researchers will follow 80 adults aged 21 and older to see which procedure provides better vision without glasses and has fewer side effects. Both surgeries reshape …
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New combo therapy may offer relief for chronic watery eyes
Symptom relief OngoingThis study compares using an anti-inflammatory eye drop (nepafenac) plus a lubricant versus a lubricant alone to treat watery eyes (epiphora) caused by narrowing of the tear duct opening. Researchers will measure changes in tear duct size and symptom severity in 68 Mexican adults…
Phase 4 • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Allergy drops under the microscope: do they really make life better for itchy eyes?
Symptom relief OngoingThis observational study looks at 100 patients with allergic conjunctivitis who received sublingual (under-the-tongue) allergen immunotherapy. Researchers will track changes in symptoms and quality of life using a standard questionnaire over 6 months. The goal is to see if this t…
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Symptom relief
Last updated Jun 26, 2026 14:24 UTC
-
Tear and blood molecules may unlock secrets of eye allergies
Knowledge-focused OngoingThis study compares small molecules called microRNAs in the tears and blood of 40 people with allergic conjunctivitis versus healthy individuals. The goal is to find patterns that could help diagnose the condition and reveal new targets for treatment. Participants are aged 5 to 3…
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC